CXCR4 and cancer: Interestingly, the downregulation of CXCR4 in these two prostate cancer cells surprisingly mimicked the effect caused by CSF-1R inhibition, as seen in Figure 2, and restored the sensitivity of cancer cells to docetaxel (Figure 3B–D).